Couple more quick question, it says the company only has 26k left in cash and 5m in debt. If the FDA wants more info, will the company have enough money to carry on? How much money does the company burn through in a month? If the FDA does approve, how will they raise funds to market their product? I noticed the company already has 109m outstanding shares, is that a lot for a small company like this? Thanks in advance.
In addition why is the total dose for Y-90 so spread out? It says the total dose for I-125 is 145Gy, the total dose for Pd-103 is 125Gy, the total dose for Cs-131 is 115Gy but the total dose for Y-90 is between 80Gy - 300Gy. That's a pretty big spread. Do they not know how much the dose will be or just no way of measuring? Pls explain this to me, thx.
The average decay energy for isotopes already in the market is about 28 kevs but Y-90's decay energy is over 2000 kevs, is that a cause for concern? Will that lead to more side effects? Has Y-90 been used in any procedures yet? Are there any papers published citing the efficacy of Y-90 in brachytherapy? I would like to know more.